CompletedNCT02449746
Immune Treatment for Psychosis With Positive Autoantibodies
About this title
Read the official source — NCT02449746Interventional studyAges 18–65United KingdomSchizophrenia
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- Birmingham and 4 more locationsSee all locations and recruitment
Study information
Study start dateStarted: August 2015
- Recruitment status
- Completed
- Enrollment listed in the registry
- 10
- Sponsor
- University of Cambridge
- Sponsor type
- University
- Study type
- Biological
- Intervention type
- Biological
- Locations
- United Kingdom
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT02449746
- Official title
Show the full official title
An Unblinded Study of the Feasibility of Plasmapheresis or Intravenous Immunoglobulin, Combined With Corticosteroids, in Patients With Acute Psychosis Associated With Anti-neuronal Membrane Auto-antibodies
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Birmingham · Cambridge · Nottingham
2 more locations
- Oxford
- Southampton
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Cambridge, a university.
Who was this study for?
Listed age limits: 18 years to 65 years.
